Japan· JP-2149022F2024
ニルバジピン
A nilvadipine product containing ニルバジピン, registered in Japan by ＬＴＬファーマ, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Nilvadipine is registered in 2 of 19 countries.
Countries holding a registration under ATC C08CA10 (nilvadipine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Nilvadipine · ATC C08CA10
2 / 19 countries
- Finlandprice
- Japan
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ニルバジピン
- Manufacturer
- ＬＴＬファーマ
- Country
- Japan (JP)
- ATC code
- C08CA10
- ATC class
- Nilvadipine
- Defined daily dose
- 8 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C08CA10
Nilvadipine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffd68f1e-418f-45c6-8018-d494d2951d5e GET /v1/drugs/ffd68f1e-418f-45c6-8018-d494d2951d5e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "４ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2149022F2024",
"category": "内用薬",
"price_yen": 14.3,
"generic_name": "ニルバジピン",
"product_name_jp": null,
"therapeutic_class": "2149",
"transitional_expiry": null
}See everything about nilvadipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.